SCHEMBL22296207

SCHEMBL22296207

Cc1ccc(N2CC(C)(O)C2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.41
CHRNB2 P17787 1/20 0.38
CHRNA4 P43681 1/20 0.38
ABL1 P00519 1/20 0.36
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
SYK P43405 1/20 0.35
MAPT P10636 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.34
SLC6A9 P48067 2/20 0.34
ADRA2A P08913 2/20 0.33
ADRA2B P18089 2/20 0.33
ADRA2C P18825 2/20 0.33
GABRA1 P14867 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
AOC3 Q16853 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24682676 0.87 PIK3CA (0.44) ELANECHRNB2CHRNA4PIK3CAMTOR
SCHEMBL15095879 0.83 PIK3CA (0.48) ELANECHRNB2CHRNA4PIK3CAMTOR
SCHEMBL1393634 0.81 NOS3 (0.38) CHRNB2CHRNA4PIK3CAMTORSYK
SCHEMBL23865820 0.81 SYK (0.35) CHRNB2CHRNA4SYKCHRNB4CHRNA3
SCHEMBL21707134 0.78 HSD11B1 (0.35) SYKCHRNB4CHRNA3
SCHEMBL23228753 0.77 ELANE (0.41) ELANECHRNB2CHRNA4SMN1; SMN2ALDH1A1
SCHEMBL22296208 0.76 CHRM4 (0.39) ELANECHRNB2CHRNA4ABL1PIK3CA
SCHEMBL15811948 0.76 HRH3 (0.45) PDE4BKCNH2
SCHEMBL17207204 0.75 ELANE (0.41) ELANECHRNB2CHRNA4PIK3CAMTOR
SCHEMBL17665098 0.75 ADRB1 (0.45) ELANEMAPTRAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3689871-A1 4,6,7-TRISUBSTITUTED 1,2-DIHYDROPYRROL[3,4-C]PYRIDIN/PYRIMIDIN-3-ONE DERIVATIVE AND USE Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (CN) 2020-08-05 EP disclosed